It was reported recently by our group that the transfection of GD3 synthase cDNA into Neuro2a cells, a neuroblastoma cell line, caused cell differentiation with neurite sprouting (Kojima et al, 1994; /. Biol Chem., 269, 30451-30456). To further explore this phenomenon in detail, we applied tetracycline-regulated system to control the expression of GD3 synthase cDNA in Neuro2a cells. Under this system, the process of Neuro2a cell differentiation was rather slow, about 3 weeks of cell culturing in the absence of tetracycline was required for most cells to extend the neurite-like structures. The RNase protection assay indicated that the mRNA of GD3 synthase gene was first detected between 4 h and 8 h after the gene was activated and kept at approximately the same level through the process. Furthermore, time-course analysis of total ganglioside expressions has shown that GD3 and GTlb gangliosides appeared on the cell surface early in the process and reached the maximum level around day 6. We also found that the amounts of GD3 and GTlb on the cell surface started to decrease after day 6 and returned gradually to the basal values after 3 weeks. On the other hand, GQlb and GDlb were started to be synthesized at early stage and the amounts were continuously to increase through the whole Neuro2a morphological change process. In addition, time-course analysis by flow cytometry method for GD3 and GQlb suggested that the conversions of simple gangliosides to more complex gangliosides may be required to induce the Neuro2a differentiation. Our results indicated that the combination of cDNA transfection and regulated gene expression is a powerful tool to study the function of glycolipids and should have a general application to the glycobiology field.
Introduction
Gangliosides are sialic acid-containing glycosphingolipids that synthesized by glycosyltransferases (Caputto et al, 1971; Paulson and Colley, 1989; van Echten and Sandhoff, 1993) . Various gangliosides in great amount have been found in brain tissues suggesting their important functional roles among neuronal cells, especially in cellular and control of cell proliferation (Suzuki, 1965; Hakomori and Igarashi, 1995; Hirschberg et al., 1996) . For example, GQlb ganglioside was reported to promote neurite outgrowth in two types of human neuroblastoma cells, GOTO and NB-1 (Tsuji et al., 1983; Nakajima et aL, 1986) . Also, differentiation of mouse neuroblastoma Neuro2a cells and rat pheochromocytoma PC 12 cells induced by exogenous addition of various gangliosides in the absence of NGF has been reported previously (Tsuji et al, 1988a,b; Ledeen et al., 1990; Mutoh et al., 1995) .
GD3 synthase (a2,8-sialyltransferase) gene has been cloned by several groups including ours from human melanoma cDNA library (Haraguchi et al., 1994; Nara et al., 1994; Sasaki et al., 1994) . This enzyme plays a key role in the biosynthesis of b-and c-series gangliosides. Recently, we have shown that by transfection the GD3 synthase cDNA into Neuro2a cells induces expression of not only GD3 but also b-series gangliosides (Scheme 1). More interestingly, the transfected Neuro2a cells show differentiation with neurite sprouting . To gain a better understanding of the consequences of GD3 synthase expressing in Neuro2a cells and explain the possible mechanism responsible for the Neuro2a morphological change, we applied the recently developed tetracycline regulated system (Gossen et al., 1993) to GD3 synthase cDNA.
Tetracycline-regulated system is an inducible gene expression system that place target gene under the control of a regulatory sequence from the tetracycline-resistance operon of TnlO (Gossen and Bujard, 1992; Gossen et al., 1993; see Figure 1, top) . When a chimeric tetracycline-controlled transactivator (tTA), a hybrid fusion protein combines the tet-repressor DNA-binding domain with the transcriptional activation domain of herpes simplex virus protein 16 (VP16), binds to the minimal promoter, the target gene (GD3 synthase cDNA) should be activated. In the presence of tetracycline, the binding of the tetracycline with the tTA prevents GD3 synthase cDNA activation by causing a conformational changes in the tetrepressor. In this study, we analyzed the time-course of GD3 mRNA and total ganglioside expressions, especially GD3 and GQlb, for stable transfected Neuro2a cells. Our strategy proved to be a useful way to study the functions of glycolipids in cellular differentiation and growth.
Results

GD3 synthase cDNA expression in tTA-Neuro2a cells was regulated by tetracycline
In order to control the GD3 synthase cDNA expression in Neuro2a cells by the tetracycline system, plasmid pCMVtTAHygro (Figure 1 , bottom) was stable transfected into the Neuro2a cells and colonies were selected by the presence of hygromycin (150 (xg/ml) in the medium. Twelve hygromycinresistant colonies were isolated and expended into the DMEM medium. All of them were stable transfected again using second plasmid pTetMCS-GD3-Neo (Figure 1 , bottom). Cells were cultured in the presence of hygromycin (150 jig/ml) and neomycin (800 (xg/rnl), colonies were chosen randomly, and A-series B-series Scheme 1. Ganglioside biosynthetic pathways. Sia, /V-acetylneuraminic acid; Gal, galactose; GIc, glucose; GalNAc, //-acetylgalactosamine; Cer, ceramide.
altogether 24 colonies were expended into the medium. All of them were cultured without tetracycline in the medium for 1 week and analyzed by flow cytometry using GD3 monoclonal antibody. Eight of them showed strong GD3 expression on the cell surface. All eight colonies were passed to the medium with tetracycline (2 (xg/ml), and cells were analyzed in 10 days by flow cytometry analysis. One of those cell lines showing strongly controlled patterns was named tTA-Neuro2a and was used as the starting cell line for later study.
Time-course analysis of GD3 synthase mRNA
To monitor the GD3 synthase mRNA expression when GD3 synthase cDNA was activated, 10 (xg of total RNA from cells cultured without tetracycline in the medium at eight stages was examined by RNase protection assay. The protection method was chosen for this study because it is more sensitive than the northern blotting method. The RNA probe (1 ng/|xl) for human GD3 synthase cDNA was made corresponding to nucleotides 666-1064 of the gene (Sasaki et al., 1994) . For internal control, housekeeping gene for glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) was used (Arcari et al, 1984) .
Our ribonuclease protection assay results indicated that the mRNA for GD3 synthase cDNA was detected between 4 h and 8 h after the gene was activated, see Figure 2 . At 4 h, the transcript was barely detected. This delayed mRNA expression pattern could be due to the characteristics of tetracycline system (Gossen et al., 1992) . Interestingly, the mRNA was maintained at about the same level through the whole tTA-Neuro2a differentiation process, that was from normal Neuro2a morphology to the one with extended neurite-outgrowth (see below). Compared to the GAPDH mRNA level, GD3 synthase mRNA was synthesized and maintained at lower level, as shown in Figure 2 .
Differentiation of tTA-Neuro2a cells induced by the expression of GD3 synthase cDNA
Under the control of tetracycline system, tTA-Neuro2a cells changed their morphology and extended axon-like structures. But this process was a rather slow one, see Exp. 1 in Figure 3 . The neurite outgrowth of some tTA-Neuro2a cells was first observed around day 5 (panel B) after the GD3 synthase cDNA was activated by the removal of tetracycline in the culture medium. The term "neurite" used here was defined as a cell with a pseudopod which exceeds one or more cell diameters in length. This morphological change process was continued gradually and the neurite outgrowth became more and more extended, as shown in panels C and D. At day 20, the majority of tTA-Neuro2a cells became neuron-like cells, panel E. On the other hand, two control experiments including double stable transfected Neuro2a cells without GD3 synthase cDNA (panels F and G) and with GD3 synthase cDNA but cultured in the presence of tetracycline in the medium (panel H) have shown that the morphology of these cells was basically the same as the parental Neuro2a cells. These results indicated that GD3 synthase cDNA expression was solely responsible for the induction of neurite outgrowth of tTA-Neuro2a cells.
To gain a better understanding of the neurite structures, the neurites were immunostained with the SMD1 monoclonal antibody. SMI31 binds to the phosphorylated neurofilaments present in axon but not in dendrites (Sternberger and Sternberger, 1983; Lichtenberg-Kraag et al., 1992) . As shown in Figure 3 , Exp. 2 (panels J and K), the neurites were immunostained strongly with SMD1 at day 20, indicating they were axon-like structures. The cell nuclei were also strongly stained reflecting the nonspecific binding using this antibody (panel I).
To distinguish the final tTA-Neuro2a cell morphology was due to real differentiation or some kind of adaptation, we stained the cells for acetylcholine esterase (Lebel et al, 1994) and the result was shown in Figure 4 . When tetracycline was presented in the culture medium, very small amount of acetylcholine esterase expression was detected. On the other hand, at the stage of day 20 without tetracycline in the culture medium, strong expression of acetylcholine esterase was detected.
To get an idea on cell proliferation rate for tTA-Neuro2a cells at several stages, a cell proliferation assay was performed using CellTiter assay, see Materials and methods. This assay is based on the cellular conversion of a tetrazolium salt into a formazan product that is detected using an ELISA plate reader. Figure 5 demonstrated that the cell proliferation rate was decreased almost 50% at day 20 comparing to 0 h.
We also tested the possibility that the differentiated tTANeuro2a cells could reverse their morphology when tetracycline was added again to the culture medium and therefore GD3 synthase cDNA expression was suppressed. The result indicated that the morphology of differentiated tTA-Neuro2a cells was irreversible.
Time-course study for total gangliosides of tTA-Neuro2a
During the process of tTA-Neuro2a differentiation induced by the expression of GD3 synthase cDNA under the control of tetracycline system, gangliosides from eight stages of cells were purified and analyzed by thin-layer chromatogram, Figure 6. At day 0, when GD3 synthase cDNA expression was suppressed by tetracycline presented in the medium, the ganglioside expression pattern from tTA-Neuro2a cells was almost the same as control Neuro2a cells, both cell lines expressed significant amounts of a-series gangliosides. When GD3 synthase cDNA was activated by the removal of tetracycline from the medium, a dramatic ganglioside expression pattern change was observed, mainly the conversion of a-series to b-series gangliosides. At day 1, small amounts of GD3, GDlb, GTlb, and GQlb were detected by TLC and GDla amount was markedly decreased. This a-series to b-series ganglioside conversion was continued through day 10, except GTlb amount started to decrease after day 3. After day 10, GD3 amount started to decrease but GQlb amount continued to increase. It was interesting to notice that there seemed to be a ganglioside content equilibrium of tTA-Neuro2a cells from day 3 to day 10.
To further examine some ganglioside changes in more detail, we measured four ganglioside (GD3, GDlb, GTlb, and GQlb) content changes by using the densitometry based on the TLC data, see Figure 7 . The results suggested that the amounts of GQlb and GDlb changed in a similar way after GD3 synthase cDNA was activated. Both ganglioside amounts increased steadily through the process. After about 3 weeks, the combined percentage of GQlb and GDlb amounts in total gangliosides was -65%. On the other hand, GD3 and GTlb ganglioside also changed in a similar pattern after the gene was activated. Both ganglioside amounts reached the peak points around day 6 and then decreased gradually to the basal Neuro2a levels after about 3 weeks culturing in the absence of tetracycline in the medium. The combined percentage of GD3 and GTlb amounts in total gangliosides was less than 10%.
Time-course analysis of GD3 and GQlb gangliosides by flow cytometry
Since GD3 and GQlb expression patterns changed significantly when GD3 synthase cDNA was activated and there seemed to be some correlation between tTA-Neuro2a differentiation and GD3, GQlb amount changes, we measured both gangliosides by staining the cells with monoclonal antibodies against GD3 and GQlb, respectively, and followed by flow Oh 4h 8h 24h 4d 15d 20d30d GD3 synthase GAPDH Oh 4h 8h 24h 4d 15d 20d30d Fig. 2 . Ribonuclease protection analysis of GD3 synthase mRNA expression during the course of tTA-Neuro2a differentiation. Ten micrograms of total RNA was hybridized to biotin labeled RNA probe (1 ng/ral) of GD3 synthase cDNA and glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) cDNA. Following digestion of single-stranded RNA, the protected probe was resolved on an acrylamide gel. cytometry analysis. tTA-Neuro2a cells were cultured and collected at several time points after GD3 synthase cDNA was made active. These time points included: 0 h, 3 h, 16 h, 24 h, day 3, day 5, day 7, day 10, day 16, day 23, and day 28. Hour 0 was defined as the point when the culture medium containing tetracycline (2 ng/ml), and the GD3 synthase cDNA expression was suppressed. For the purpose of clarity, flow cytometry analysis data from six representative time points (Oh, 16 h, day 3, day 10, day 16, and day 23) were shown in Figure 8 . In the case of GD3 (Figure 8a) , at 0 h, the amount on the cell surface was about the same as control Neuro2a cells in negligible amounts. But GD3 synthesis increased gradually and reached a high level at day 3 after tetracycline was removed from the culture medium and was kept approximately at that level until day 10. Amount of GD3 started to decrease at a slow but steady rate after 10 day culturing without tetracycline. GD3 ganglioside continued to decrease to the control Neuro2a level all the way to about day 23 when the majority of the tTA-Neuro2a cells started to extend the axon-like structures. On the other hand, for GQlb ganglioside (Figure 8b ), there was a small increase of GQlb synthesis on cell surface compared to the control Neuro2a cells at 0 h. That could be due to the leakage caused by small percentage of cells that were controlled more loosely by the tetracycline system. When the suppression for GD3 synthase cDNA was lifted by removal of tetracycline from the medium, the GQlb peak on flow cytometry analysis started to shift from the control Neuro2a peak gradually, and this trend was kept continuously through the whole process. A second peak for GQlb of the flow cytometry data could be seen starting from about the 3 day point, indicating the uneven amounts of GQlb presented among cell population. The flow cytometry results correlated well with the TLC data.
Discussion
In this study, we used the neuroblastoma cell line Neuro2a as a model system to study the functions of gangliosides on cell morphological change and neurite outgrowth. We examined the changes and roles of cell surface gangliosides by transfection and expression of the GD3 synthase cDNA, which encodes a key enzyme for ganglioside synthesis. The expression of GD3 synthase cDNA was controlled by the recently developed tetracycline system. Under this system, the Neuro2a cells changed to the neuron-like cells with the characteristic phenotype of differentiated neurons with neurite extensions.
The tetracycline system is a newly developed inducible gene expression system that overcomes many of the limitations encountered by other systems, including basal leakiness and toxic effects by inducer (Gossen et al., 1993) . Although the system works well, there are still problems of low levels of expression for the inducible gene and sometimes uneven expression among controlled cells (Gossen et al., 1992) . In our tetracycline system for GD3 synthase cDNA in Neuro2a cells, this low expression level was confirmed by the RNase protection assay (see Figure 2 ).
There were several indications suggesting that the final morphological change for tTA-Neuro2a was a stage of cell differentiation. First of all, at morphological level, tTA-Neuro2a at late culturing stage extended neurite-like structures, and it was immunostained positive using SMI31 antibody, which binds to the phosphorylated neurofilaments present in axon but not in dendrites. Secondly, tTA-Neuro2a cells cultured without tetracycline in the medium at late stages showed decreased cell proliferation and expressed acetylcholine esterase, indicating differentiation of the cells. Furthermore, the neurite outgrowth process was irreversible when tetracycline was added again into the culture medium.
It has been known for some time that exogenous addition of gangliosides causes the morphological changes of cultured cells and the process is rapid, within a day (Tsuji et al., 1983 (Tsuji et al., , 1988a . Under the tetracycline system, GD3 synthase cDNA transfected tTA-Neuro2a cells changed their morphology in a much slower manner, it took about 3 weeks for the majority of cells to extend their neurites after the GD3 synthase cDNA was activated. Although the underlying mechanism was unclear to us at this stage, there were two possible explanations for this phenomenon, one was that (1) the GD3 synthase mRNA was expressed and kept at a low level during the process under the tetracycline system. The slow turnover of gangliosides might be due to the low GD3 synthase mRNA expression level. As indicated by Figures 6 and 8 , changes in the expression levels and types of gangliosides marked the beginning for tTANeuroia cell morphological change to neuron-like cells with characteristic phenotypes. The conversion of simple gangliosides, e.g., GD3 to more complex ganglioside GQlb may be essential for the process of Neuro2a cell differentiation. (2) It was possible that some unidentified signal transduction system, which links to some transcription activation system related to neurite formation, was responsible for tTA-Neuro2a morphological change under the tetracycline system. Recently, we have identified two new genes that were involved in this process by differential display method. Both genes seemed to be developmentally regulated in the mouse brain (Liu and Tsuji, unpublished observations).
It was shown recently that GD3 and GT3 are synthesized by a single enzyme in human and therefore GD3 synthase is also GT3 synthase (Nakayama et ai, 1996) . However, we found recently that only driving by strong promoters, such as CMV promoter, GD3 synthase gene behaved as the GT3 synthase gene (unpublished observations). In this study, we also did flow cytometry analysis on tTA-Neuro2a cells using monoclonal antibody against GT3. Our results (data not shown) indicated that there was not any GT3 synthesized during the process of tTA-Neuro2a morphological change. Therefore, in our system, GD3 synthase enzyme did not show the capacity as GT3 synthase. Also, the synthesis of GD3 and other b-series gangliosides was a slow process under our system. We also notice some difference when comparing the present tetracycline regulated system to our previous nonregulated system (Kojima et ai, 1994) . In the previous system, because the gene expression was not controlled and there was no timing process involved, GD3 expression was also detected in addition to the GQlb expression. This could also be due to the different promoters used to drive the GD3 synthase cDNA.
There is some evidence suggesting Trk A protein (Mutoh et ai, 1995) , ceramide (Riboni et ai, 1995) , and consequent MAPK activation may be responsible for the differentiation of Neuro2a cells. Although the underlying molecular mechanism remains poorly understood, there is suggestion that GM1 mimics the effects of NGF and activates the Trk A signal transduction. We also measured the NGF levels for tTA-Neuro2a cell medium at several culturing stages, including both 0 h and day 20 cell stages. The result indicated that NGF did not change significantly at different stages, suggesting other mechanism for this process (H. Liu, S. Furukawa, and S. Tsuji, unpublished observations).
Several studies have shown that the expression of gangliosides during brain development are strictly regulated (Yu et al., ) were harvested at days 0, 1, 3, 6, 10, 13, 16, and 20 after removing tetracycline in the culture medium. Gangliosides in the cells were extracted. After drying under nitrogen stream, the resulting gangliosides were dissolved in chloroform:methanol (1:1). The samples (10 ml, 3 x 10 6 cells) were applied on a HPTLC plate and developed with chloroform:methanol:0.5% CaCl 2 (55:45:10). The plate was visualized with orcinol-H 2 S0 4 . Gangliosides were quantified by densitometry using SIMADZU CS-9300PC densitometer.
1988; Svennerholm et al., 1991; Rosner et al., 1992) . GD3 is expressed at the early stage of development, during neural tube formation and neuroblast and glioblast proliferation. At the late stage of development, that is at neurogenesis and neuritogenesis stage, diminished expression of GD3 and increased synthesis of other b-series gangliosides including GQlb are observed. Our time-course study based on the flow cytometry analysis for GD3 and GQlb and TLC analysis on several gangliosides during the process of Neuro2a differentiation also indicated the similar ganglioside change pattern. Taken together, our results indicated that stable transfection of glycosyltransferase cDNA into neuroblastoma cell lines modifies the de novo biosynthesis of gangliosides; in conjunction with the gene regulated system, it is a powerful tool to study the functions of various gangliosides on cell fate at defined stages of cell development and the signal transduction pathway involved.
Materials and methods
Plasmid constructions
The original tetracycline-inducible expression plasmids pUHD 10-3 (pTetMCS) and pUHD 15-1 (pCMVtTA) were generously provided by H. Bujard (Gossen et al, 1992) . The pTetMCS plasmid contains a cytomegalovirus (CMV) minimal promoter linked to seven repeat units of the Escherichia coli tetracycline operator. The pCMVtTA plasmid contains the CMV promoter and enhancer and the tetR-VP16 fusion. To construct the plasmid pTetMCS-GD3-Neo, complete GD3 cDNA was amplified by PCR with primers 5' CCTAGATCTTTGTGCTGAGGCC 3' and 5' TTCTTCAGATCTATT-GTTCCTAGGAAGTG 3 r (underlines indicated synthetic Bglll restriction sites) using pUCl 19-GD3R (Sasaki et al, 1994) as template. The PCR fragment was digested with Bglll and inserted into the BamHI site of pTetMCS. A 1.13 kb fragment containing TK promoter, neomycin gene, and polyA signal was excised from pMClneoPOLA (Stratagene) and was ligated into the Xhol site of pTetMCS-GD3. The final plasmid obtained was named pTetMCS-GD3-Neo. To construct the plasmid pCMVtTA-Hygro, a 1.7 kb fragment containing the TK promoter, complete Hygromycine gene, and polyA signal was amplified by PCR with primers 5' GTCTGGGCCCAAGCTTGGCACTGGGAT 3' and 5' AACCCCGCGAAGCTTTATGAACAAACGAC 3' (underlines indicated synthetic Hindlll restriction sites) using p3'SS (Stratagene) as template. The PCR fragment was digested with Hindlll and inserted into the Hindlll site of pCMVtTA. The final plasmid obtained was named pCMVtTA-Hygro.
Transfection, generation of stable transformed cells
Murine neuroblastoma Neuro2a cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM) (GIBCO-BRL, Grand Island, NY) supplemented with 10% (v/v) heat-inactivated fetal calf serum (FCS) and antibiotics at 37°C in 5% CO 2 .
Plasmid pCMVtTA-Hygro was transfected into a 60-mm-diameter plate of Neuro2a cells using the LipofectAMINE reagent (GIBCO-BRL) following the manufacture's recommended protocol. Colonies were selected in the presence of Hygromycin (150 ji.g/ml). Twelve colonies were picked randomly and expended, transfected again with plasmid pTetMCS-GD3-Neo also using the LipofectAMINE reagent. Colonies were selected again in the presence of G418 (800 |xg/ml, GIBCO) as well as Hygromycin (150 (xg/ml) but without tetracycline in the culture medium. Colonies were screened by flow cytometry analysis using monoclonal antibody against GD3. Twenty-four Hygromycin and G418-resistant colonies were picked up randomly and expended into culture medium. Eight of them showed strong GD3 expression on the cell surface. All eight colonies were then cultured in the medium containing tetracycline (2 p.g/ml) for 10 days and analyzed by flow cytometry again staining the cells with GD3 antibody. Three of them showed strongly controlled GD3 expression pattern by tetracycline. One of them was chosen randomly and used for the study of this article. This cell line was named tTA-Neuro2a.
Flow cytometry analysis, immunofluorescence microscopy, and cell proliferation assay
The detailed procedures for flow cytometry analysis and immunofluorescence microscopy were described previously . Briefly, for flow cytometry analysis, cells were harvested with 0.02% EDTA solution and washed with PBS containing 1% bovine serum albumin and 0.05% NaN 3 ' and then treated with GD3, GQlb monoclonal antibodies (KM643, KM647, kindly provided by Dr. Nobuo Hanai, Kyowa Kakkou Co.), and SMI31 (kindly provided by Dr. S. Hitoshi, RIKEN) at 10 p-g/ml for 2 h on ice. The control antibody of mouse IgGl was also used. After washing with PBS containing 1% bovine serum albumin and 0.05% NaN 3 , the cells were treated with a FITClabeled goat F(ab')2 fragment of anti-mouse IgG and anti-mouse IgM mixture (1:40 dilution; TAGO Inc., Burlingame, CA) for 30 min at 4"C and then subjected to flow cytometry using a FACSFlow (Becton Dickinson). For immunofluorescence microscopy analysis, after culture medium was removed, the cells were fixed with 1 % paraformaldehyde for 20 min at room temperature and stained as described above.
For cell proliferation assay, Promega's CellTiter 96 kit was used according to the manufacturer's directions.
Ribonuclease protection analysis of tTA-Neura2a cells
Total RNA from tTA-Neuro2a cells at several different time points after removal of tetracycline from the medium was isolated using RWeasy method (QIAGENE). Ribonuclease protection assays were performed using the RPA II kit (Ambion) according to the manufacture's directions. For internal control, housekeeping gene for glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) was used (Arcari et al, 1984) . To make the probe for GD3 synthase gene and GAPDH gene, 400 bp and 450 bp fragments were amplified by PCR using pUC119-GD3R as template for GD3 and mouse brain cDNA library for GAPDH. The primers for GD3 gene were 5' GCGGATCCCTTTTCTAT-GAAGACAGGAACAG 3' (synthetic BamHI site was underlined) and 5' GCAAGCTTGTGGGCTGGAGTGAGGTATCTTC 3' (synthetic Hindffl site was underlined). The primers for GAPDH gene were 5' GCGGATCCACCA- ) were harvested at day 0, 1, 3, 6, 10, 13, 16, and 20 after removing tetracycline in the culture medium. Gangliosides in the cells were extracted with 4 ml of 2-propanol:hexane:water (55:25:20) and dried under nitrogen stream. Phospholipids, cholesterol, and neutral glycolipids were removed by Folch's partitioning. The upper layer of Folch's partitioning was collected, dried under nitrogen stream, dissolved in water, and then applied on a C-18 column (Sep-Pak Vac, 100 mg; Waters, Milford, MA) equilibrated with PBS. After the column was washed with 1 ml of PBS and 2 ml water, gangliosides adsorbed on the column were eluted 1 ml of merhanol and 1 rrU of chloroform:methanol (1:1). After drying under nitrogen stream, the resulting gangliosides were dissolved in 30 u.1 of chloroform:methanol (1:1). The samples (10 p.1, 3 x 10* cells) were applied on a HPTLC plate (Merck) and then the plate was developed with chloroform:methanol:0.5% CaCl 2 (55:45: 10). The plate was visualized with orcinol-H 2 SO 4 . Gangliosides were quantified by densitometry using SIMADZU CS-930OPC densitometer.
Acctylcholine esterase staining of cells
The procedure for acetylcholine esterase staining was based on Tago et at, 1986 . Briefly, cells were fixed with 1% paraformaldehyde in PBS, washed with 0.1 M sodium malate (pH 6.0), and then incubated for 1 h with a substrate solution comprising 72 \iM acetylthiocholirjc iodide, 10 jiM K 3 Fe(CN) 6JSO \iM C 0 S0 4 , and 100 u.M sodium citrate in 0.1 uJvi sodium maleate buffer (pH 6.0). After a second incubation for 10 min with 0.04% 3,3'-diaminobenzudine and 0.3% nickel ammonium sulfate in 50 mM Tris-HCl (pH 7.5), 0.003% H 2 O 2 (final concentration) was added to the reaction mixture, followed by incubation for a further 25 min. Fig. 8 . Tune-course analysis of GD3 and GQlb gangliosides using flow cytometry method. The black areas represent tTA-Neuro2a cells at 0 h, which had almost the same pattern as parent Neuro2a cells, (a) GD3 ganglioside change, (b) GQlb ganglioside change. tTA-Neuro2a cells at several stages were harvested using an EDTA solution and washed with PBS. The cells were then treated with 20 u.g/ml anti<5D3 mAb or anti-GQlb mAb for 2 h on ice. For the control, cells were treated with 20 u-g/ml mouse IgGl. After washing with PBS containing 1% bovine serum albumin and 0.05% NaN 3 , cells were treated with a FTTC-labeled goal F(ab')2 fragment of anti-mouse IgG and anti-mouse IgM mixture (1:40 dilution) for 30 min at 4°C and then subjected to flow cytometry.
